In its 23rd year, Discovery on Target is the premier event highlighting “hot” drug targets and emerging modalities, technologies, and strategies for pursuing those targets. The numerous conferences, symposia, courses, and training...
Non-viral gene delivery is rapidly transforming the landscape of cell and gene therapy, particularly in the wake of the FDA’s boxed warning on viral vector–based CAR-T products and the first...
Life Sciences Future is the annual meeting of the Pennsylvania life sciences ecosystem. From biotechnology, medical device and diagnostics, pharmaceuticals to research institutions, investment organizations, and strategic advisors, all key stakeholders...
Join Us In Washington, D.C.! Cell and gene therapies are transforming healthcare, but their full potential depends on a supportive policy landscape. Join policymakers, industry leaders, and science stakeholders to explore...
BVS in collaboration with Cambridge Scientific Labs is hosting an outdoor Biotech Community Oktoberfest Event in Watertown. Mark your calendars for a great opportunity to connect with industry leaders, explore...
We are very excited to announce our outdoor Ventura BioCenter Life Science Community Event in Thousand Oaks! Mark your calendars for a great opportunity to connect with industry leaders, explore...
The MedTech Conference brings top industry executives and thousands of global innovators together in San Diego. This year’s conference comes at a critical time for the medtech industry, building on...
Designed to catalyze transformation in global clinical research, CORE 2025 brings together leaders across biotech, pharma, regulatory agencies, and digital health to define the future of clinical development, scale innovation...
Explore the evolving landscape of analytical services, where complex drug modalities and innovative technologies converge to support the development of biologics, cell and gene therapies, and small molecule therapeutics. This...
Discover the crucial role CDMOs play in the development and manufacturing of Antibody-Drug Conjugates (ADCs). These groundbreaking therapies, combining monoclonal antibodies with cancer cell-targeting payloads, offer precise targeting and powerful...
